Clinical significance of antibodies to PCNA
スポンサーリンク
概要
- 論文の詳細を見る
- 1998-03-01
著者
関連論文
- Activated peripheral blood mononuclear cells detected in lupus patients using cDNA coding for proliferating cell nuclear antigen
- Successful treatment of severe Reiter's Syndrome with etretinate
- Glyceraldehyde 3-phosphate dehydrogenase is a novel autoantigen leading autoimmune responses to proliferating cell nuclear antigen multiprotein complexes in lupus patients
- Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits
- Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population
- Multicenter cooperative study of HLA class II alleles in Japanese patients with systemic lupus erythematosus
- Decrease in CD4^+CD25^+ and CD8^+CD28^+ T cells in interstitial pneumonitis associated with rheumatic disease
- Cavitary lung lesion in a patient with systemic lupus erythematosus : an unusual manifestation of cytomegalovirus pneumonitis
- Improvement of rapidly progressive lupus nephritis associated MPO-ANCA with tacrolimus
- Long-term prognosis in lupus nephritis: relation to the renal biopsy data, therapy, and grade of remission
- Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease
- Anti-Ki antibodies recognize an epitope homologous with SV40 nuclear localization signal : clinical signifficance and reactivities in various immunoassays
- Investigation of pathological and clinical features of lupus nephritis in 73 autopsied cases with systemic lupus erythematosus
- Scleredema : report of a case
- A case of intestinal Behcet's disease in association with HLA-B27 and HLA-B51
- Cyclosporin A therapy for interstitial pneumonitis associated with rheumatic disease
- A case of mixed connective tissue disease associated with macrovascular lesions in the upper and lower extremities
- A case of very-late-onset systemic lupus erythematosus
- Anti-proteasome activator 28α is a novel anti-cytoplasmic antibody in patients with systemic lupus erythematosus and Sjogren's syndrome
- CD19/22 balance relates to improvement of disease activity in systemic lupus erythematosus
- Sjogren syndrome associated with multiple myeloma of the lgA _k-type
- A case of inclusion body myositis with systemic sclerosis
- Analysis of autoantibodies to cell cycle-assosiated antigens
- Cyclosporine treatment of advanced interstitial pneumonitis associated with systemic sclerosis
- 2-2). The Expression of LFA-1, ICAM-1, CD80 and CD86 Molecules in Lupus Patiens : Implication for Immunotherapy
- Relation between the levels of soluble CD4, CD8 and CD23 molecules in sera and clinical manifestations and laboratory data in patients with systemic lupus erythematosus
- Central nervous system involvements of patients with systemic lupus erythematosus
- Clinical significance of antibodies to PCNA
- Antineutrophil cytoplasmic antibodies against myeloperoxidase, proteinase 3, elastase, cathepsin G and lactoferrin in Japanese patients with rheumatoid arthritis
- Regenerating gene (REG) 1 alpha promotes pannus progression in patients with rheumatoid arthritis
- Cumulative association of eight susceptibility genes with systemic lupus erythematosus in a Japanese female population
- Rheumatoid arthritis complicated with immunodeficiency-associated lymphoproliferative disorders during treatment with adalimumab
- Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in Japan